文献速递乳腺乳腺X线

基于乳腺X线摄影的深度学习模型在三年一次筛查项目中预测乳腺癌风险的评估

Evaluation of a Mammography-based Deep Learning Model for Breast Cancer Risk Prediction in a Triennial Screening Program.
PubMed 文献 · Radiology · 2025-01-01

本研究回顾性分析英国乳腺筛查项目中134217例阴性数字乳腺X线筛查,评估深度学习算法Mirai的3年风险评分对间期癌的预测能力。1年、2年、3年间期癌预测AUC分别为0.72、0.67、0.67,各年龄四分位组与BI-RADS乳腺密度组间无显著差异;最高20%评分女性中回顾性预测了42.4%(222/524)的间期癌。

要点

  • Mirai 3年风险评分在阴性筛查后1年AUC为0.72、2年0.67、3年0.67。
  • 最高20%评分女性回顾性覆盖42.4%(222/524)的间期癌。
  • 各年龄四分位组与BI-RADS a–d密度组预测性能无显著差异。

核心结论

  • Mirai可识别适合更频繁筛查或额外影像检查的女性,从而更早检出间期癌。

研究设计与样本

  • 回顾性研究,纳入2014年1月至2016年12月3年队列中两个中心、两种主要乳腺X线摄影系统的阴性数字筛查图像,共134217次检查(134217名女性,平均年龄59.1岁±7.9),含524例间期癌;参考标准为阴性筛查后40个月内经组织病理学确认无乳腺癌诊断。

关键影像表现/征象

  • 深度学习算法Mirai处理数字筛查乳腺X线摄影图像并生成3年风险评分。
  • 排除筛检发现的癌症(基线及下一轮)、植入物及非标准体位图像。

诊断标准与关键数值

  • 1年间期癌预测AUC为0.72(95%CI:0.65,0.78),2年为0.67(95%CI:0.64,0.70),3年为0.67(95%CI:0.65,0.70)。
  • 年龄四分位组C指数:小于52岁为0.67(95%CI:0.62,0.71),52–58岁为0.70(95%CI:0.65,0.75),59–65岁为0.71(95%CI:0.67,0.75),66岁及以上为0.71(95%CI:0.67,0.75)。
  • BI-RADS a、b、c、d类C指数分别为0.70(95%CI:0.62,0.78)、0.69(95%CI:0.65,0.73)、0.68(95%CI:0.64,0.71)、0.67(95%CI:0.62,0.73)。
  • 最高1%、5%、10%、20%评分女性分别回顾性预测3.6%(19/524)、14.5%(76/524)、26.1%(137/524)、42.4%(222/524)的间期癌。
  • 1年、2年、3年间期癌预测性能无显著差异(P≥.63),年龄四分位组间无显著差异(P≥.73),乳腺密度组间无显著差异(P≥.99)。

临床应用与阅片要点

  • 作者认为Mirai可识别适合更频繁筛查或额外影像检查的女性,从而更早检出间期癌。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Deep learning risk algorithms for personalized breast cancer screening outperform traditional methods in retrospective evaluations, but triennial screening assessments are lacking. Purpose To evaluate the predictive ability of 3-year risk scores generated by a deep learning algorithm (Mirai) to identify women who developed interval cancers (ICs) in the UK breast screening program, which invites women aged 50-70 years for triennial mammography. Materials and Methods For this retrospective study, Mirai processed digital screening mammograms with negative results collected from a 3-year cohort (January 2014 to December 2016) across two sites and two primary mammography systems. Exclusions included screen-detected cancers (baseline and next round), implants, and nonstandard views. The reference standard was no cancer diagnosis within 40 months of negative screening, confirmed histopathologically. The primary objective was predicting ICs at 1-, 2-, and 3-year time points after baseline screening. Secondary objectives were assessing predictions across age quartiles and Breast Imaging Reporting and Data System (BI-RADS) breast densities. Areas under the receiver operating characteristic curve (AUCs) and true positives (ICs) were calculated across operating thresholds. Risk score distributions were compared with the Mann-Whitney U test, and AUCs were compared with the DeLong test. Results Analysis included 134 217 examinations from the same number of women (mean age, 59.1 years ± 7.9 [SD]), including 524 ICs. There was no evidence of performance differences among 1-, 2-, and 3-year IC predictions (P ≥ .63), age quartiles (P ≥ .73), or breast densities (P ≥ .99). Overall AUCs were 0.72 (95% CI: 0.65, 0.78), 0.67 (95% CI: 0.64, 0.70), and 0.67 (95% CI: 0.65, 0.70) for 1-, 2-, and 3-year IC predictions, respectively. C indexes for age quartiles were 0.67 (95% CI: 0.62, 0.71) for age younger than 52 years, 0.70 (95% CI: 0.65, 0.75) for age 52-58 years, 0.71 (95% CI: 0.67, 0.75) for age 59-65 years, and 0.71 (95% CI: 0.67, 0.75) for age of 66 years and older. C indexes for BI-RADS categories a, b, c, and d were 0.70 (95% CI: 0.62, 0.78), 0.69 (95% CI: 0.65, 0.73), 0.68 (95% CI: 0.64, 0.71), and 0.67 (95% CI: 0.62, 0.73), respectively. Three-year risk scores retrospectively predicted 3.6% (19 of 524), 14.5% (76 of 524), 26.1% (137 of 524), and 42.4% (222 of 524) of ICs for women assigned the highest 1%, 5%, 10%, and 20% of scores. Conclusion Mirai could identify women for more frequent screening or additional imaging, detecting ICs earlier. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Philpotts in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Rothwell JWD, Rogers P, Payne NR, et al. Evaluation of a Mammography-based Deep Learning Model for Breast Cancer Risk Prediction in a Triennial Screening Program. Radiology. 2025. PMID: 41147910. doi:10.1148/radiol.250391

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。